Umbralisib Tosylate (TGR-1202) is a potent, selectively dual inhibitor targeting PI3Kdelta and casein kinase-1-epsilon (CK1epsilon), demonstrating oral activity. With EC50 values of 22.2 nM and 6.0 µM for PI3Kdelta and CK1epsilon respectively, it shows unique immunomodulatory eff